This inventor holds 1 USPTO granted patent. Top assignee: Harbin Medical University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Xiaona Li in Molecular Imaging
Introduction
Xiaona Li is a prominent inventor based in Harbin, China. She has made significant contributions to the field of molecular imaging and drug delivery systems. Her innovative work focuses on integrating diagnosis and treatment through advanced nano-probe technology.
Latest Patents
Xiaona Li holds a patent for a "Diagnosis-treatment integrated nano-probe for F-MR/fluorescence multi-mode molecular imaging and drug-loading and preparation method and application of nano-probe." This invention provides a novel approach to molecular imaging and drug delivery. The nano-probe is designed to enhance in-vivo 19F-MR molecular imaging capabilities. It utilizes a nanoparticle formed by coating a mixture of a surfactant containing a molecular targeting treatment drug and a fluorescent dye with a Perfluorocarbon (PFC) carrier. This innovative design allows for targeted binding and treatment of tumors, improving the anaerobic microenvironment and achieving a chemosensitization effect.
Career Highlights
Xiaona Li is affiliated with Harbin Medical University, where she conducts her research and development activities. Her work has garnered attention for its potential applications in cancer treatment and diagnostics. With a focus on integrating imaging and therapeutic strategies, she is paving the way for advancements in medical technology.
Collaborations
Xiaona Li collaborates with notable colleagues, including Xilin Sun and Lina Wu. Their combined expertise contributes to the innovative research and development of new medical technologies.
Conclusion
Xiaona Li's contributions to molecular imaging and drug delivery systems exemplify the potential of innovative technologies in medicine. Her work not only enhances diagnostic capabilities but also improves treatment outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile